Evidence map›Paper›PMID 39355389›Full record

ArticleWorld journal of radiology2024

Behcet's disease-related panuveitis following COVID-19 vaccination: A case report.

Rou-Ting Lin, Pei-Kang Liu, Chia-Wei Chang, Kai-Chun Cheng, Kuo-Jen Chen, Yo-Chen Chang

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of radiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. An overview of HLA variants in COVID-19 vaccine-induced autoimmunity.International journal of molecular epidemiology and genetics · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rou-Ting LinSchool of Medicine, College of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.
Pei-Kang LiuDepartment of Ophthalmology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80737, Taiwan.
Chia-Wei ChangDepartment of Clinical Education and Training, Kaohsiung Medical University Hospital, Kaohsiung 80756, Taiwan.
Kai-Chun ChengDepartment of Ophthalmology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80737, Taiwan.
Kuo-Jen ChenDepartment of Ophthalmology, Kaohsiung Municipal Siaogang Hospital, Kaohsiung Medical University, Kaohsiung 81201, Taiwan.
Yo-Chen ChangDepartment of Ophthalmology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80737, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBehcet's disease (BD) is an inflammatory disorder known for various symptoms, including oral and genital ulcers and ocular inflammation. Panuveitis, a severe eye condition, is rare as the first sign of BD. CASE SUMMARY: We present an unusual case of a 30-year-old man who developed panuveitis after receiving the mRNA-based coronavirus disease 2019 (COVID-19) vaccine (Moderna). Laboratory tests ruled out infections, but he had a positive HLA-B51 result and a history of genital ulcer and oral ulcers, leading to a BD diagnosis. Treatment with corticosteroids improved his condition. Interestingly, he had another episode of panuveitis after the second mRNA vaccine dose, which also responded to corticosteroids.

conclusionThis case highlights the rare onset of BD following mRNA COVID-19 vaccination, suggesting a potential link between these vaccines and BD's eye symptoms, emphasizing the importance of quick treatment in similar cases.

Indexed as

Behcet’s diseaseCase reportmRNA COVID-19 vaccineOcular inflammationPanuveitis

Identifiers

PMID39355389
PMCPMC11440273

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.